array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(25) "Gsk Consumer Health, Inc."
["slug"]=>
string(32) "4abba-us-gsk-consumer-health-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/8434ac9a-9bf2-4877-a3a0-a4039c237204"
["description"]=>
string(518) "GSK Consumer Healthcare is a global business that discovers, develops, and manufactures innovative consumer healthcare products. It is an associate of GlaxoSmithKline plc, one of the world's largest healthcare companies. GSK Consumer Healthcare aims to become one of the world's most innovative, best performing, and trusted healthcare companies. Their goal is to improve lives through scientific innovation, build category-defining brands, and become Pakistan's first and best Fast Moving Consumer Healthcare Company."
["address_street"]=>
string(28) "184 Liberty Corner Rd Ste 78"
["address_place"]=>
string(6) "Warren"
["address_region"]=>
string(10) "New Jersey"
["founding_date"]=>
string(10) "1994-02-28"
["website_domain"]=>
string(7) "gsk.com"
["website_url"]=>
string(19) "https://www.gsk.com"
["industry_codes"]=>
array(1) {
[0]=>
string(27) "Pharmaceutical Preparations"
}
["employee_count"]=>
int(300)
["article_count"]=>
int(452)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(127) "Major Pharmaceutical Companies Adapt to Changing Consumer Health Market through Divestments and Strategic Shifts - News Biggest"
["snippet_en"]=>
string(156) "Pfizer is selling approximately 630 million shares of Haleon, which will lower its stake in the company from 32% to around 24%. This transaction is expected"
["url"]=>
string(137) "https://newsbiggest.com/major-pharmaceutical-companies-adapt-to-changing-consumer-health-market-through-divestments-and-strategic-shifts/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/eb0e8b0b-fd0c-42b6-abb5-5655bb4dc43a"
["source"]=>
string(15) "newsbiggest.com"
["publication_date"]=>
string(10) "2024-03-18"
["categories"]=>
array(6) {
[0]=>
string(11) "Acquisition"
[1]=>
string(25) "Business Model Resilience"
[2]=>
string(8) "spin-off"
[3]=>
string(24) "Stock Research & Ratings"
[4]=>
string(18) "General Investment"
[5]=>
string(12) "Stock Market"
}
}
[1]=>
array(7) {
["title_en"]=>
string(81) "Analysis of companies that are in the news: Bayer, ENI and the Real Estate Sector"
["snippet_en"]=>
string(312) "We offer you the analysis of some of the companies that are in the news today, Bayer, ENI and the Real Estate Sector, carried out by the Bankinter Analysis Department (Bankinter Blog): Bayer Bayer is not expected to announce a spin-off and sale of businesses According to Bloomberg , the Company does not foresee"
["url"]=>
string(69) "https://www.megabolsa.com/2024/01/19/bayer-eni-y-sector-inmobiliario/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/50f59648-cff2-4d07-95e4-707f65716c22"
["source"]=>
string(13) "megabolsa.com"
["publication_date"]=>
string(10) "2024-01-19"
["categories"]=>
array(3) {
[0]=>
string(17) "Consumer Behavior"
[1]=>
string(25) "Business Model Resilience"
[2]=>
string(23) "Real estate development"
}
}
[2]=>
array(7) {
["title_en"]=>
string(87) "GSK considering expanding its respiratory business with Verona Pharma and its COPD drug"
["snippet_en"]=>
string(87) "GSK considering expanding its respiratory business with Verona Pharma and its COPD drug"
["url"]=>
string(59) "https://www.merca2.es/2024/01/03/gsk-verona-pharma-1530796/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/b38e2896-a81f-4186-a8b2-31e7a0f364aa"
["source"]=>
string(9) "merca2.es"
["publication_date"]=>
string(10) "2024-01-02"
["categories"]=>
array(3) {
[0]=>
string(18) "Expansion & Growth"
[1]=>
string(20) "Business Development"
[2]=>
string(25) "Business Model Resilience"
}
}
[3]=>
array(7) {
["title_en"]=>
string(48) "GSK recognized as a Business Example #PorElClima"
["snippet_en"]=>
string(113) "The pharmaceutical company is part of the 10 large companies and 10 SMEs that are a model to follow in this field"
["url"]=>
string(128) "https://www.consalud.es/salud35/sostenibilidad/reconocen-gsk-ejemplo-empresarial-clima-compromiso-medio-ambiente_137104_102.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/e51e62ec-f3a1-4394-a5f6-1427b68dcdb4"
["source"]=>
string(11) "consalud.es"
["publication_date"]=>
string(10) "2023-11-21"
["categories"]=>
array(3) {
[0]=>
string(20) "Business Development"
[1]=>
string(25) "Business Model Resilience"
[2]=>
string(22) "Business Restructuring"
}
}
[4]=>
array(7) {
["title_en"]=>
string(50) "GSK consumer health spin-off Haleon starts trading"
["snippet_en"]=>
string(299) "GSK's consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with a price of 330 pence and a market valuation of around £31 billion ($37 billion). The new company– which has achieved the largest London listing in a decade– has annual sales of"
["url"]=>
string(80) "https://pharmaphorum.com/news/gsk-consumer-health-spin-off-haleon-starts-trading"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/c103aeff-d491-48f8-9773-cc329e43e37c"
["source"]=>
string(16) "pharmaphorum.com"
["publication_date"]=>
string(10) "2022-07-18"
["categories"]=>
array(8) {
[0]=>
string(24) "Quarterly/Annual Figures"
[1]=>
string(15) "Market Movement"
[2]=>
string(9) "Valuation"
[3]=>
string(25) "Business Model Resilience"
[4]=>
string(12) "Going Public"
[5]=>
string(11) "Competition"
[6]=>
string(20) "Conflict of Interest"
[7]=>
string(8) "spin-off"
}
}
[5]=>
array(7) {
["title_en"]=>
string(69) "Pfizer to exit GSK consumer health joint venture after London listing"
["snippet_en"]=>
string(68) "US pharma group to sell down stake in Haleon business after July IPO"
["url"]=>
string(63) "https://www.ft.com/content/85f28cd9-ca18-4f2b-8346-c22efdfe1382"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/e34c335d-d226-4780-91d7-3c2c05e08aa6"
["source"]=>
string(6) "ft.com"
["publication_date"]=>
string(10) "2022-06-01"
["categories"]=>
array(9) {
[0]=>
string(11) "Acquisition"
[1]=>
string(20) "Business Development"
[2]=>
string(10) "Divestment"
[3]=>
string(8) "Downtime"
[4]=>
string(25) "Business Model Resilience"
[5]=>
string(12) "Going Public"
[6]=>
string(13) "Collaboration"
[7]=>
string(18) "General Investment"
[8]=>
string(12) "Stock Market"
}
}
[6]=>
array(7) {
["title_en"]=>
string(91) "GlaxoSmithKline -GSK- reinforces its oncology segment with new acquisition - CONSULTORSALUD"
["snippet_en"]=>
string(160) "GlaxoSmithKline or GSK for short is a pharmaceutical company of British origin with a great position in the world market, which occupies the number one position"
["url"]=>
string(62) "https://consultorsalud.com/glaxosmithkline-refuerza-oncologia/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/dfeb08f1-2d30-4323-86c8-6773d186954a"
["source"]=>
string(18) "consultorsalud.com"
["publication_date"]=>
string(10) "2022-04-21"
["categories"]=>
array(4) {
[0]=>
string(11) "Acquisition"
[1]=>
string(21) "Competitive Behaviour"
[2]=>
string(25) "Business Model Resilience"
[3]=>
string(18) "Expansion & Growth"
}
}
[7]=>
array(7) {
["title_en"]=>
string(58) "Haleon, the new independent company of GSK Consumer Health"
["snippet_en"]=>
string(274) "Haleon is the new Consumer Healthcare company, independent of GSK (GlaxoSmithKline). With an outstanding portfolio of globally renowned brands such as Sensodyne, Voltaren, Panadol and Centrum and annual sales of approximately £10 billion, the company is poised to achieve a"
["url"]=>
string(85) "https://www.bursa.ro/haleon-noua-companie-independenta-a-gsk-consumer-health-07347540"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/1f119112-95bf-4f9e-9703-9164fdc745a2"
["source"]=>
string(8) "bursa.ro"
["publication_date"]=>
string(10) "2022-02-23"
["categories"]=>
array(3) {
[0]=>
string(18) "Ecological Impacts"
[1]=>
string(24) "Quarterly/Annual Figures"
[2]=>
string(25) "Business Model Resilience"
}
}
[8]=>
array(7) {
["title_en"]=>
string(70) "GSK will make its consumer division an independent company in mid-2022"
["snippet_en"]=>
string(196) "GlaxoSmithKline will separate the self-care health products division from its business in mid-2022. As reported by the British multinational, the commercial name of the new company will be Haleon."
["url"]=>
string(155) "https://www.eleconomista.es/empresas-finanzas/noticias/11631365/02/22/gsk-hara-de-su-division-de-consumo-una-compania-independiente-a-mediados-de-2022.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/c5f29c27-66cc-4252-abdd-3c27ebc67d74"
["source"]=>
string(15) "eleconomista.es"
["publication_date"]=>
string(10) "2022-02-22"
["categories"]=>
array(3) {
[0]=>
string(11) "Name Change"
[1]=>
string(25) "Business Model Resilience"
[2]=>
string(22) "Business Restructuring"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(28)
}
[1]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(27)
}
[2]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(26)
}
[3]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(21)
}
[4]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(20)
}
[5]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(18)
}
[6]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(17)
}
[7]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(16)
}
[8]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(15)
}
[9]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(14)
}
[10]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(14)
}
[11]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(13)
}
[12]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(12)
}
[13]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(11)
}
[14]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(10)
}
[15]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(10)
}
[16]=>
array(2) {
["name"]=>
string(20) "Business Development"
["count"]=>
int(9)
}
[17]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(9)
}
[18]=>
array(2) {
["name"]=>
string(13) "Data Security"
["count"]=>
int(8)
}
[19]=>
array(2) {
["name"]=>
string(16) "Customer Welfare"
["count"]=>
int(7)
}
[20]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(7)
}
[21]=>
array(2) {
["name"]=>
string(19) "Economic Conditions"
["count"]=>
int(6)
}
[22]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(6)
}
[23]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(6)
}
[24]=>
array(2) {
["name"]=>
string(6) "Crisis"
["count"]=>
int(6)
}
[25]=>
array(2) {
["name"]=>
string(21) "Cultural developments"
["count"]=>
int(6)
}
[26]=>
array(2) {
["name"]=>
string(7) "Layoffs"
["count"]=>
int(6)
}
[27]=>
array(2) {
["name"]=>
string(10) "Divestment"
["count"]=>
int(6)
}
[28]=>
array(2) {
["name"]=>
string(24) "Employee Health & Safety"
["count"]=>
int(6)
}
[29]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(5)
}
}
}
4abba-us-gsk-consumer-health-inc
Gsk Consumer Health, Inc.
Location
New Jersey
Founded
1994-02-28
Website
https://www.gsk.com
Articles
452 Articles
Category
Pharmaceutical Preparations
Description
GSK Consumer Healthcare is a global business that discovers, develops, and manufactures innovative consumer healthcare products. It is an associate of GlaxoSmithKline plc, one of the world's largest healthcare companies. GSK Consumer Healthcare aims to become one of the world's most innovative, best performing, and trusted healthcare companies. Their goal is to improve lives through scientific innovation, build category-defining brands, and become Pakistan's first and best Fast Moving Consumer Healthcare Company.
Pfizer is selling approximately 630 million shares of Haleon, which will lower its stake in the company from 32% to around 24%. This transaction is expected
We offer you the analysis of some of the companies that are in the news today, Bayer, ENI and the Real Estate Sector, carried out by the Bankinter Analysis Department (Bankinter Blog): Bayer Bayer is not expected to announce a spin-off and sale of businesses According to Bloomberg , the Company does not foresee
GSK's consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with a price of 330 pence and a market valuation of around £31 billion ($37 billion). The new company– which has achieved the largest London listing in a decade– has annual sales of
GlaxoSmithKline or GSK for short is a pharmaceutical company of British origin with a great position in the world market, which occupies the number one position
Haleon is the new Consumer Healthcare company, independent of GSK (GlaxoSmithKline). With an outstanding portfolio of globally renowned brands such as Sensodyne, Voltaren, Panadol and Centrum and annual sales of approximately £10 billion, the company is poised to achieve a
GlaxoSmithKline will separate the self-care health products division from its business in mid-2022. As reported by the British multinational, the commercial name of the new company will be Haleon.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
